Cancer Immunotherapy Market Share

Market Share of Cancer Immunotherapy Industry

The cancer immunotherapy market is highly competitive and consists of a few major players. Companies like Amgen Inc., Astellas Pharma Inc., AstraZeneca, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., F. Hoffman La Roche, Merck and Co., Novartis, and OSE Immunotherapeutics, among others, hold a substantial share in the cancer immunotherapy market. The market players have also been significantly investing in R&D for cancer therapy, which along with the increasing product approvals, are further driving the market growth.

Cancer Immunotherapy Market Leaders

1. Amgen Inc.

2. Astellas Pharma, Inc.

3. AstraZeneca PLC

4. Merck and Co Inc.

5. OSE Immunotherapeutics

*Disclaimer: Major Players sorted in no particular order